Van Cleef Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,308
| Closed | -$1.3M | – | 111 |
|
|
2023
Q1 | $1.3M | Hold |
16,308
| – | – | 0.2% | 53 |
|
|
2022
Q4 | $1.1M | Hold |
16,308
| – | – | 0.18% | 56 |
|
|
2022
Q3 | $812K | Hold |
16,308
| – | – | 0.16% | 58 |
|
|
2022
Q2 | $909K | Hold |
16,308
| – | – | 0.15% | 56 |
|
|
2022
Q1 | $906K | Sell |
16,308
-1,000
| -6% | -$51.3K | 0.13% | 60 |
|
|
2021
Q4 | $969K | Hold |
17,308
| – | – | 0.14% | 62 |
|
|
2021
Q3 | $831K | Hold |
17,308
| – | – | 0.13% | 64 |
|
|
2021
Q2 | $725K | Hold |
17,308
| – | – | 0.11% | 73 |
|
|
2021
Q1 | $583K | Hold |
17,308
| – | – | 0.09% | 79 |
|
|
2020
Q4 | $604K | Sell |
17,308
-450
| -3% | -$15.6K | 0.1% | 75 |
|
|
2020
Q3 | $616K | Hold |
17,758
| – | – | 0.12% | 71 |
|
|
2020
Q2 | $581K | Hold |
17,758
| – | – | 0.12% | 72 |
|
|
2020
Q1 | $535K | Hold |
17,758
| – | – | 0.13% | 70 |
|
|
2019
Q4 | $514K | Sell |
17,758
-450
| -2% | -$12.5K | 0.1% | 83 |
|
|
2019
Q3 | $471K | Hold |
18,208
| – | – | 0.1% | 80 |
|
|
2019
Q2 | $465K | Hold |
18,208
| – | – | 0.1% | 79 |
|
|
2019
Q1 | $476K | Hold |
18,208
| – | – | 0.11% | 78 |
|
|
2018
Q4 | $419K | Sell |
18,208
-740
| -4% | -$16.4K | 0.11% | 76 |
|
|
2018
Q3 | $447K | Hold |
18,948
| – | – | 0.1% | 76 |
|
|
2018
Q2 | $437K | Hold |
18,948
| – | – | 0.1% | 79 |
|
|
2018
Q1 | $467K | Hold |
18,948
| – | – | 0.12% | 75 |
|
|
2017
Q4 | $508K | Sell |
18,948
-420
| -2% | -$10.7K | 0.13% | 79 |
|
|
2017
Q3 | $466K | Hold |
19,368
| – | – | 0.13% | 77 |
|
|
2017
Q2 | $415K | Hold |
19,368
| – | – | 0.12% | 75 |
|
|
2017
Q1 | $332K | Hold |
19,368
| – | – | 0.1% | 79 |
|
|
2016
Q4 | $347K | Sell |
19,368
-622
| -3% | -$11.3K | 0.11% | 79 |
|
|
2016
Q3 | $416K | Hold |
19,990
| – | – | 0.14% | 75 |
|
|
2016
Q2 | $538K | Hold |
19,990
| – | – | 0.19% | 66 |
|
|
2016
Q1 | $542K | Hold |
19,990
| – | – | 0.19% | 65 |
|
|
2015
Q4 | $581K | Hold |
19,990
| – | – | 0.21% | 63 |
|
|
2015
Q3 | $542K | Hold |
19,990
| – | – | 0.21% | 62 |
|
|
2015
Q2 | $547K | Hold |
19,990
| – | – | 0.2% | 64 |
|
|
2015
Q1 | $534K | Hold |
19,990
| – | – | 0.2% | 63 |
|
|
2014
Q4 | $423K | Hold |
19,990
| – | – | 0.16% | 73 |
|
|
2014
Q3 | $476K | Hold |
19,990
| – | – | 0.2% | 64 |
|
|
2014
Q2 | $462K | Hold |
19,990
| – | – | 0.19% | 64 |
|
|
2014
Q1 | $456K | Hold |
19,990
| – | – | 0.2% | 62 |
|
|
2013
Q4 | $369K | Hold |
19,990
| – | – | 0.16% | 70 |
|
|
2013
Q3 | $338K | Hold |
19,990
| – | – | 0.17% | 71 |
|
|
2013
Q2 | $310K | Buy |
+19,990
| New | +$333K | 0.16% | 74 |
|
Other funds holding NVO
F
Van Cleef Asset Management's NVO Position: Q2 2023 in Review
Van Cleef Asset Management sold out of Novo Nordisk (NVO) in Q2 2023, closing a stake of 16,308 shares — an estimated $1.3M sold.
Van Cleef Asset Management first reported a position in NVO in Q2 2013 and held it in 40 quarters. The position peaked at $1.3M in Q1 2023. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.
- Van Cleef Asset Management reported no remaining Novo Nordisk position as of Q2 2023 after selling out during the quarter.
- Van Cleef Asset Management sold 16,308 Novo Nordisk shares in Q2 2023, an estimated $1.3M.
- Van Cleef Asset Management first reported a position in Novo Nordisk in Q2 2013 and held it in 40 quarters.
- Van Cleef Asset Management's Novo Nordisk position peaked at $1.3M in Q1 2023.
- 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.
Based on Van Cleef Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.